Skip to main content

JE Ledgerwood

First name:
JE
Last name:
Ledgerwood
Gaudinski, M. ., Coates, E. ., Houser, K. ., Chen, G. ., Yamshchikov, G. ., Saunders, J. ., … Study, T. V. 606. (2018). Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults. PLoS Medicine, 15(1), e1002493. https://doi.org/10.1371/journal.pmed.1002493
Sahly, H. E., Baden, L. ., Essink, B. ., Doblecki-Lewis, S. ., Martin, J. ., Anderson, E. ., … Study, G. C. (2021). Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase. The New England Journal of Medicine, 385(19), 1774-1785. https://doi.org/10.1056/NEJMoa2113017 (Original work published 2021)